Tumor Cell-Derived TGFβ1 Attenuates Antitumor Immune Activity of T Cells via Regulation of PD-1 mRNA

Pengfei Wu1,2, Bo Geng1, Qun Chen3

  • 1Department of Urology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Insights

Tumor-derived TGFβ1 increases PD-1 mRNA in T cells, hindering antitumor activity in clear cell renal cell carcinoma (ccRCC). This mechanism offers a potential therapeutic target for ccRCC immunotherapy.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • T-cell dysfunction, marked by high programmed cell death-1 (PD-1) expression, drives clear cell renal cell carcinoma (ccRCC) progression.
  • The precise molecular mechanisms sustaining PD-1 elevation in ccRCC T cells remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms regulating PD-1 expression at the mRNA level in ccRCC.
  • To investigate the functional impact of these mechanisms on T-cell dysfunction and antitumor activity.

Main Methods:

  • Transcriptomic analysis of ccRCC samples to identify correlations between TGFβ1 and PD-1 mRNA.
  • In vitro and in vivo investigations using syngeneic tumor models to study PD-1 mRNA regulation.
  • Analysis of TGFβ1's prognostic significance and its association with PD-1 mRNA expression.

Main Results:

  • A correlation between TGFβ1 and PD-1 mRNA levels was identified in ccRCC.
  • TGFβ1 activates P38 and H3 phosphorylation, leading to increased SRSF3/SRSF5 expression in T cells, prolonging PD-1 mRNA half-life.
  • SRSF3 facilitates PD-1 mRNA export, and TGFβ1-induced SRSF3 restricts T-cell antitumor activity, impacting immunotherapy outcomes in mouse models.

Conclusions:

  • Tumor-derived TGFβ1 promotes immune evasion in ccRCC by upregulating PD-1 expression in T cells.
  • TGFβ1 serves as a potential prognostic biomarker and therapeutic target for ccRCC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K